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ABSTRACT OF THESIS 
 
DEVELOPMENT AND CHARACTERIZATION OF AN IN VITRO EQUINE 
AIRWAY MODEL AS A TOOL FOR THE STUDY OF HOST-PATHOGEN 
INTERACTIONS AT THE EPITHELIAL CELL BARRIER 
 
 
Equine influenza virus (EIV) and equine herpesvirus-1 (EHV-1) are the main causes of 
viral respiratory diseases in horses. Despite vaccination efforts, they continue to have 
serious health and economic impacts on the equine industry. While we have made 
progress understanding the host adaptive immune response to these viruses, the innate 
and early immune response remains poorly defined. One reason for this delay in our 
understanding of this essential component of immunity is the lack of a suitable in vitro 
model. The respiratory epithelium is the primary site of infection and replication for both 
EIV and EHV-1 and the site where early immune responses occur. As a component of 
innate immunity, it also functions as a physical barrier, chemical barrier, and 
microbiological barrier against pathogen invasion through the formation of tight 
junctions, mucociliary clearance, and the harboring of commensal microorganisms as 
well as antimicrobial peptides important for facilitating pathogen clearance. Because of 
the importance of the respiratory epithelium in the pathogenesis of equine respiratory 
viruses, we developed and characterized, morphologically and immunologically, an 
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equine respiratory epithelial cell (EREC) culture system grown at the air-fluid interface 
(AFI). The AFI culture system is unique because the model mimics the natural airway 
epithelium with the apical surface of the cells exposed to humidified air while the basal 
surface is submerged in liquid. In addition, respiratory epithelial cell cultures grown at 
the AFI have been successfully developed for other species and used as a tool in the study 
of allergy and infectious disease.  
To develop an equine airway model, respiratory epithelial tissues were harvested 
from humanely euthanized horses and epithelial cells were isolated using enzymatic 
digestion and gentle agitation in calcium and magnesium free minimal essential medium 
for 48 hours. ERECs were seeded on a collagen-coated membrane and kept at an air-fluid 
interface until differentiated. Factors that determined the point of differentiation included 
tight junction formation, mucin production, and cilia development. After four weeks of 
growth, we have demonstrated cell differentiation in these cultures characterized by the 
presence of ciliated epithelial cells, secretory cells, and basal cells in addition to tight 
junction formation and visible mucin production.  
While AFI cultures have been shown to undergo successful cell differentiation, 
little information exists as to how they present immunologically after several weeks of in 
vitro growth conditions. Equine respiratory epithelial tissues, isolated epithelial cells, and 
four-week old cultured, differentiated airway epithelial cells collected from six locations 
of the equine respiratory tract were examined for the expression of toll-like receptors 
(TLRs) and antimicrobial peptides (AMPs) using conventional polymerase chain reaction 
(PCR). Cultured, differentiated, respiratory epithelial cells and freshly isolated respiratory 
epithelial cells were also examined for the expression of TLR3, TLR9 and major 
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histocompatibility complex (MHC) class I and class II using fluorescence-activated cell 
sorting (FACS) analysis. In addition, cytokine and chemokine profiles from respiratory 
epithelial tissues, freshly isolated respiratory epithelial cells, and cultured, differentiated, 
epithelial cells from the upper respiratory tract were examined using real-time PCR. We 
found that respiratory epithelial tissues and isolated epithelial cells expressed TLRs 1-4 
and 6-10 as well as AMPs, MxA, 2’5’ OAS, β-defensin-1, and lactoferrin. In contrast, 
TLRs 8-10 and lactoferrin were no longer detected in epithelial cells cultured at the AFI 
after four weeks compared to respiratory tissues and freshly isolated epithelial cells. In 
addition, MHC-I and MHC-II surface expression decreased in epithelial cells cultured at 
the AFI compared to isolated epithelial cells whereas TLR3 and TLR9 were expressed at 
similar levels. Lastly, we found that after four weeks of in vitro growth conditions, 
equine respiratory epithelial cells cultured at the AFI expressed granulocyte-macrophage 
colony-stimulating factor (GM-CSF), IL-10, IL-8, TGF-β, TNF-α, and IL-6. 
To further define the use of this model, we examined the infectivity and 24 hour 
endpoint M gene copy numbers in these cultures using canine and equine H3N8 influenza 
A viruses and compared this to an in vivo study using the same influenza isolates in 
ponies. Our results demonstrated that infectivity and 24 hour endpoint M gene copy 
numbers in the primary EREC culture system mirrored viral nasal shedding seen in the in 
vivo pony challenge. More specifically, we demonstrated restricted infectivity of a 
contemporary canine influenza A isolate in the EREC AFI culture and in ponies 
compared to efficient infection of both in vitro and in vivo models using a contemporary 
equine influenza isolate as a positive control.  
 vi 
In summary, we have developed an in vitro equine respiratory epithelial cell 
culture model that is morphologically similar to the equine airway epithelium, retains 
several key immunological properties, and supports viral infection and replication. In the 
future this model will be used to study equine respiratory viral pathogenesis and cell-to-
cell interactions.  
 
Ayshea Mary Quintana 
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Colorado State University 
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CHAPTER 1: INTRODUCTION 
 
Equine respiratory disease 
 Equine influenza virus (EIV) and equine herpesviruses (EHV-1) are the main 
causes of viral respiratory disease in equids.1-5 EHV-1 is ubiquitous among horse 
populations with seasonal epidemics. Incidences of EHV-1 appear to increase during 
higher foaling periods and in winter through early spring.6,7 EIV is endemic in horses 
with epidemics occurring during horse racing events.8-10 Despite vaccination efforts, EIV 
and EHV-1 continue to have serious health and economic consequences for the equine 
industry.5,11-13 Effective vaccination against EIV and EHV-1 is strongly dependent on the 
ability of vaccines to induce long-term protective immunity.14-16 For EIV, protective 
immunity has been shown to be associated with robust humoral immune responses 
against influenza hemagglutinin and neuraminidase glycoproteins.17 Moreover, protection 
against EIV is correlated with the antigenic relatedness of the vaccine strain to circulating 
isolates.18,19 However, antigenic drift has had considerable adverse affects on the efficacy 
of EIV vaccines.19 For EHV-1, protection is directly correlated with a cytotoxic T-
lymphocyte response.20-22 There’s evidence that EHV-1 evades this response through the 
down-modulation of major histocompatibility complex (MHC) class I23 making the 
development of an effective vaccine a challenging task. While much progress has been 
made in understanding the adaptive immune response to EIV and EHV-1,15,24  the innate 
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and early immune responses at the initial site of viral infection and replication remain 
poorly characterized. As respiratory epithelium is the primary site of infection and 
replication for EIV and EHV-1, studying the initial immune response to these viruses at 
the epithelial cell barrier is critical for a better understanding of host-pathogen 
interactions at this site, and how this interaction affects further downstream events 
including adaptive immune responses. 
 
Innate and early immunity 
Innate immunity encompasses the earliest forms of defense against pathogen 
invasion by initiating an immediate response to infection. This involves the recognition 
of pathogens by endogenous, preformed, pathogen recognition receptors that 
subsequently lead to the activation of effector molecules and effector mechanisms. These 
pattern recognition receptors (PRRs) include toll-like receptors, nod-like receptors, and 
RNA helicases that function to recognize pathogen associated molecular patterns 
(PAMPs) subsequently mediating pathogen clearance.25-27 Toll-like receptors (TLRs) are 
a unique family of PRRs. They are highly conserved type I transmembrane proteins first 
discovered in Drosophila melanogaster.28 Structurally, TLRs contain an intracytoplasmic 
domain that is shared with members of the interleukin-1 receptor family.29 The 
extracellular domain of TLRs contain amino terminal leucine rich repeats,29 which are 
likely involved directly in PAMP recognition. Currently, thirteen TLRs have been 
characterized in humans, ten in bovines, and as many as sixteen TLRs have been 
described in certain species of fish.30 As PRRs are broadly specific, they are able to 
recognize various PAMPs (Table 1.1). 
 3 
Table 1.1. PRRs, cellular localization and their known associated pathogen ligands 
PRR Cellular 
location 
PAMP recognition Reference 
TLR 1/2 Plasma 
membrane 
Triacylated lipopeptides 31,32 
TLR 2/6 Plasma 
membrane 
Diacylated lipopeptides, viral envelope 
proteins, lipoprotein, peptidoglycan, 
lipoarabinomannan, zymosan 
31,32 
TLR 3 Endosome  Viral double stranded RNA 31,32 
TLR 4 Plasma 
membrane 
Lipopolysaccharide, viral envelope protein 31,32 
TLR 5 Plasma 
membrane 
Bacterial flagellin 31,32 
TLR 7/8 Endosome Viral single stranded RNA 31,32 
TLR 9 Endosome Double stranded DNA viruses, unmethylated 
CpG DNA 
31,32 
TLR 10 Plasma 
membrane 
Unknown 33 
TLR 11 Plasma 
membrane 
Uropathogenic bacteria, profilin 32 
TLR 12 Plasma 
membrane 
Unknown  






NOD 1 & 
NOD 2 
Cytosol Peptidoglycan, diaminopimelic acid (NOD1) & 




Cytosol Viral double stranded RNA 37 
 
As key components of innate immunity, TLRs and the complement system can be 
activated rapidly to act as mediators during the transition from innate to adaptive 
immunity.38 Often studied as separate entities, it has become increasingly clear that 
crosstalk may occur between TLRs and the complement system, in which TLR agonists 
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activate complement in addition to initiating TLR signaling.39,40 Several cells of the 
innate immune response express PRRs including macrophages, dendritic cells, natural 
killer cells, mast cells, neutrophils, eosinophils and epithelial cells.41,42 
Recognition of PAMPS by PRRs induces a signaling cascade that activates 
transcription factors leading to the production and regulation of proinflammatory 
cytokines, chemokines, and antimicrobial peptides as well as an upregulation of 
costimulatory molecules, and recruitment of professional immune cells.43-45 Cytokines 
and chemokines are regulatory proteins involved in an intricate network that interact with 
receptors on cell surfaces facilitating cell-to-cell signaling and communication. Cell 
responses to cytokine and chemokine signaling usually occur in an autocrine (within the 
cell) and paracrine (on adjacent cells) manner and occasionally in an endocrine (on 
distant cells) fashion. As a result, cytokine and chemokines are potent effector molecules 
important in regulating and shaping downstream adaptive immune responses. 
In addition to cytokine and chemokine production, signaling through TLRs also 
results in the expression of antimicrobial peptides classically associated with mucosal 
surfaces. Antimicrobial peptides (AMPs) are small proteins with demonstrated 
antimicrobial and antiviral activity and are fundamental components of innate 
immunity.48 They inhabit several physiologic locations and are broadly classified 
according to their structure (Table 1.2). While mechanisms of action vary depending on 
the AMP, they generally exert inhibitory activity through electrostatic interactions with 
bacterial cytoplasmic membranes and viral envelope proteins.56-59 AMPs have also been 
demonstrated to direct monocyte differentiation toward macrophages through 
granulocyte- macrophage colony-stimulating factor (GM-CSF) regulation.43 
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Table 1.2.  Classes of antimicrobial peptides 


















































amphibians Airway epithelium 
49 
 
In addition they were demonstrated to activate monocyte-derived dendritic cells and 
modulate IFN-γ production in antigen-presenting cells suggesting they may also play a 
role in the shaping of adaptive immunity.60,61 These early innate immune responses 
involving the recruitment of professional immune cells through cytokine signaling can 




Pathogen recognition by epithelial cells 
For EIV and EHV-1, early immunity occurs at the respiratory epithelium, the 
initial site of host-pathogen interactions for respiratory viruses. Therefore, epithelial cells 
play a central role in the induction of early immunity. In addition to pathogen 
recognition, PRRs along the epithelial cell barrier are essential to maintaining 
homeostasis through the sampling of the external environment, which consists of 
pathogens as well as non-pathogenic commensal microorganisms.62,63 These interactions 
prime and condition the immune response and facilitate epithelial cell crosstalk with 
underlying immune cells including antigen-sampling dendritic cells.62 As professional 
immune cells are known to secrete regulatory cytokines and chemokines (Table 1.3), 
epithelial cells have also been demonstrated to produce IL-1, IL-3, IL-6, IL-8, IL-33, 
GM-CSF, MCP-1, TGF-α, TGF-β, and TNF-α supporting their role in the regulation of 
host immunity.64-66 It has become clear that airway epithelial cells are able to regulate the 
recruitment and function of professional immune cells through the secretion of 
cytokines.67 Conventional cultures of rat trachea epithelial cells were demonstrated to 
produce the cytokine, GM-CSF, a potent activator of macrophages, neutrophils and 
eosinophils.67 Moreover, it was shown that secretion of GM-CSF by rat trachea epithelial 
cells triggered a proliferation of macrophages indicating that GM-CSF secreted by 
epithelial cells can regulate professional immune cells.67 In addition, previous studies 
have demonstrated the expression of TNF-α, TGF-β, IL-8, IL-10 and IL-6, by airway 
epithelial cells.72-74 Lastly, as AMPs primarily inhabit mucosal surfaces, the expression of 
cathelicidins, lactoferrin, β-defensins, secretory leukocyte protease inhibitor (SLPI), 
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maximin, dermicidin, and MxA have been demonstrated in airway epithelial cells (Table 
1.2).50,75-78 




  Type 1 Type 2 
Others 




CD4 T-cell IFN-γ, IL-12, TNF-β IL-3, IL-4, IL-5, 
IL-6, IL-9, IL-10, 
IL-13, IL-21,  
IL-17, GM-
CSF 
CD8 T cell IL-2, IFN-γ IL-4, IL-5, IL-10  IL-17 
NK cell IFN-γ, TNF-β   
Monocyte/macrophage IL-12, IL-27 IL-3 GM-CSF, 
MCP-1 
B cell IL-12, TNF-β   
Dendritic cell IL-12, IL-27, IFN-α, 
IFN-β 
  
Neutrophil IL-12   
Mast cell  IL-4, IL-5, IL-6  





Antigen-presentation by epithelial cells 
 Major histocompatibility complexes (MHC) are essential components in 
facilitating pathogen clearance and function by binding and presenting short antigenic 
peptides on the surface of immune cells to T-cell receptors. The MHC genes are divided 
into three groups: MHC class I (MHC-I), MHC class II (MHC-II), and MHC class III 
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though only MHC-I and MHC-II are capable of antigen processing and presentation. 
MHC-III genes encode other immune components such as complement and cytokine 
components but do not encode antigen-processing molecules. MHC-I and MHC-II differ 
not only in antigen processing, but also in the type of T-cell for which they present 
peptide-MHC complexes. For example, CD8 T-cells recognize peptides processed in the 
cytosol, transported to the endoplasmic reticulum for additional modification and loaded 
onto MHC-I complexes,79 while CD4 T-cells recognize exogenous antigenic peptides 
processed in intracellular vesicles and loaded onto MHC-II complexes.80 
While all nucleated cells express MHC-I, only professional antigen-presenting 
cells such as dendritic cells, macrophages, and B-cells are known to express MHC-II. In 
addition, certain types of epithelial cells are known to process and present antigen 
through MHC-II presentation, namely thymic epithelial cells,81,82 intestinal epithelial 
cells,83,84 and renal tubular epithelial cells.85-87 However, little information exists on 
whether airway epithelial cells express MHC-II and are capable of processing and 
presenting antigen to professional immune cells. In fact, dendritic cells have been 
regarded as the antigen-presenting cell of the airways. Recently, a study demonstrated 
increased surface expression of MHC-II in immortalized human bronchial epithelial cells 
in response to stimulation with organic particulate matter88 suggesting natural airway 
epithelial cells may also function as professional antigen-presenting cells providing an 






Epithelial cell barrier 
The mucosal defense at the respiratory epithelium comprises physical, chemical, 
and microbiological barriers to evade pathogens. Examples of physical barriers include 
tight junctions, adherens junctions, and mucociliary clearance. Tight junctions and 
adherens junctions function to regulate solute transport and cell permeability while 
forming a barrier from the external environment.89 Respiratory epithelium is a unique 
environment comprised of ciliated pseudostratified columnar epithelial cells, secretory 
cells such as Goblet cells, and basal cells that function to maintain airway homeostasis 
while providing protection from antigens brought in from the external environment 
through respiration.26 
As resident structural cells, airway epithelial cells lie at an interface that separates 
the external and internal environments of the respiratory tract.26 Mucociliary clearance is 
an important physical barrier in airway epithelia that involves the coating of pathogen 
and debris with mucin proteins preventing them from adhering to the epithelium and 
moving them out of the airway through the movement of cilia.26 In addition, respiratory 
mucus is a complex array of highly charged mucin glycoproteins produced by secretory 
cells that function in preventing dehydration of the apical surface of the airway epithelial 
cell, as well as harboring host protective proteins.26  
Fatty acids, enzymes, and antimicrobial peptides are examples of chemical 
barriers that are important components of innate immunity and can exhibit direct activity 
on pathogens resulting in limited growth, reduced pathogen entry into host cells, and a 
decrease in viral replication.90-92 Microbiological barriers include commensal 
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microorganisms of the normal flora lining epithelial surfaces that compete with invading 
pathogens for space and nutrients. 
 
Models of airway epithelium 
Our lack of understanding of innate and early immunity at the primary site of 
infection and replication or airway pathogens is partly the result of a lack of a suitable in 
vitro model. Earlier conventional models of respiratory epithelial cell cultures were 
established by fully immersing cells in media.96-98 One limitation to this method is the 
loss of respiratory epithelial cell differentiation over time.99,100 In contrast, the 
development of a biphasic hamster airway epithelial cell culture model provided a 
powerful new technique to culture airway epithelial cells that re-established and 
maintained characteristics of cell differentiation.101 Airway epithelial cell culture models 
grown at the air-fluid interface (AFI) have since been developed for other species 
including human, rat, mouse, bovine, and swine as a tool to study allergy and infectious 
disease.102-107 Recently, successful culture of differentiated equine bronchial epithelial 
cells cultured at the AFI has been described.108 Morphologically, respiratory epithelial 
cells cultured at the AFI appear to mimic the natural airway epithelium as a 
heterogeneous population of ciliated cells, basal cells, and secretory cells generating a 
pseudo-stratified mucociliary epithelium contrary to what is seen with respiratory 
epithelial cells cultured submerged in liquid.109,110 In addition, secretion of mucin 
proteins has been characterized in human, rat, and equine differentiated respiratory 
epithelial cell cultures grown at the AFI.108,109,111 Moreover, tight junction formation 
characteristic to epithelial cells and responsible for creating a physical barrier has also 
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been demonstrated through transepithelial electrical resistance (TEER) 
measurements.109,112 Finally, respiratory epithelial cells cultured at the AFI have been 
demonstrated to support viral infection and replication supporting their use as a tool to 
study host-pathogen interactions at the respiratory epithelial barrier.113,114 While 
respiratory epithelial cells cultured at the AFI are known to mimic the natural airway 
epithelium and support viral replication, no information exists on how these culture 




 The goal of this project was to establish and characterize a primary equine 
respiratory epithelial cell culture system in terms of morphological and immunological 
properties, to study host-pathogen interactions at the epithelial cell barrier to equine viral 
respiratory diseases. The first paper outlines the morphological features of ERECs 
cultured at the AFI after four weeks with respect to tight junction formation, production 
of mucus, and development of ciliated epithelial cells. Moreover, since EREC AFI 
cultures are grown in vitro, immunological properties including expression of toll-like 
receptors and antimicrobial peptides are described and compared to natural airway 
epithelium and isolated uncultured epithelial cells. MHC-I and MHC-II surface 
expression in ERECs cultured at the AFI is compared to isolated uncultured ERECs. In 
the second paper, ERECs cultured at the AFI were infected with H3N8 canine and equine 
influenza A viruses and compared to an in vivo experimental challenge using these same 
influenza isolates as a way to support the use of this model. This study demonstrated 
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successful infection of ERECs cultured at the AFI and viral infection and replication 
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Currently, our understanding of innate immunity within the equine respiratory tract is 
limited. As the first interface to undergo pathogen invasion, the respiratory epithelium 
plays a key role in the immediate defense as well as the shaping of the adaptive immune 
response. For this reason, we examined the innate immune characteristics of the equine 
respiratory tract and compared them to an in vitro equine respiratory epithelial cell model 
cultured at the air-fluid interface (AFI). Respiratory epithelial tissues, isolated epithelial 
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cells, and four-week old cultured, differentiated airway epithelial cells collected from six 
locations of the equine respiratory tract were examined for the expression of toll-like 
receptors (TLRs) and antimicrobial peptides (AMPs) using conventional polymerase 
chain reaction (PCR). Cultured, differentiated, respiratory epithelial cells and freshly 
isolated respiratory epithelial cells were also examined for the expression of TLR3, TLR9 
and major histocompatibility complex (MHC) class I and class II using fluorescence-
activated cell sorting (FACS) analysis. In addition, cytokine and chemokine profiles from 
respiratory epithelial tissues, freshly isolated respiratory epithelial cells, and cultured, 
differentiated, epithelial cells from the upper respiratory tract were examined using real-
time PCR. We found that respiratory epithelial tissues and isolated epithelial cells 
expressed TLRs 1-4 and 6-10 as well as AMPs, MxA, 2’5’ OAS, β-defensin-1, and 
lactoferrin. In contrast, TLRs 8-10 and lactoferrin were no longer detected in epithelial 
cells cultured at the AFI after four weeks compared to respiratory tissues and freshly 
isolated epithelial cells. In addition, MHC-I and MHC-II surface expression decreased in 
epithelial cells cultured at the AFI compared to isolated epithelial cells, whereas TLR3 
and TLR9 were expressed at similar levels. Lastly, we found that after four weeks of in 
vitro growth conditions, equine respiratory epithelial cells cultured at the AFI expressed 
granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-10, IL-8, TGF-β, 
TNF-α, and IL-6. In summary, we have developed an in vitro equine respiratory 
epithelial cell culture model that is morphologically similar to the equine airway 
epithelium and retains several key immunological properties. In the future this model will 




AFI  Air-fluid interface 
FACS  Fluorescence-activated cell sorting 
TLR  Toll-like receptor 
AMP  Antimicrobial peptide 
EIV  Equine influenza virus 
EHV-1  Equine herpesvirus-1 
EREC  Equine respiratory epithelial cell 
PRR  Pattern recognition receptor 
PAMP  Pathogen-associated molecular pattern 
GM-CSF Granulocyte-macrophage colony-stimulating factor 
MCP-1 Monocyte chemoattractant protein-1 














Respiratory pathogens such as equine influenza (EIV) and equine herpesvirus-1 
(EHV-1) continue to have serious health and economic impacts on the equine industry,1,2 
despite vaccination. While in recent years we have made progress understanding the 
adaptive immune response to these common respiratory pathogens,2,3 the innate immune 
response remains poorly characterized.  
Elucidating the innate immune response to these viruses is important, as the early 
events following infection not only determine whether the virus can establish infection 
but also set the stage for downstream adaptive immune responses.  Initiation of innate 
immunity relies on the activation of germline encoded pattern recognition receptors 
(PRRs) through the recognition of pathogen-associated molecular patterns (PAMPs).4 
Toll-like receptors (TLRs) are classic PRRs that are found on immune cells as well as 
mucosal epithelia exposed to invading pathogens. Thirteen mammalian TLRs have been 
identified of which TLRs 2-4 and 7-9 have been identified in horses.4-6 These TLRs 
function to recognize various pathogen ligands including lipopolysaccharides, diacylated 
and triacylated lipopeptides, flagellin, single-stranded and double stranded RNA, and 
CpG motifs among others.4,5 Recognition of invading pathogens by PRRs results in a 
signaling cascade that leads to the production of cytokines, chemokines, and 
antimicrobial peptides (AMPs). Cytokines and chemokines are key mediators that initiate 
immediate immune responses and ultimately shape the adaptive immune response via 
chemoattraction, activation of immune cells, and up-regulation of co-stimulatory 
molecules for antigen presentation.4 Antimicrobial peptides are small proteins with 
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demonstrated antimicrobial and antiviral activity.7,8 Moreover, AMPs have been shown to 
activate monocyte-derived dendritic cells and modulate IFN-γ production in antigen-
presenting cells suggesting they may also play a role in the shaping of adaptive 
immunity.9,10 
For respiratory pathogens, including EHV-1 and EIV, the respiratory epithelium 
is the first to encounter and interact with invading pathogens and initiate early immune 
responses. In recent years it has become evident that as this first line of defense, epithelial 
cells are multifunctional, playing an important role in immunity in addition to providing a 
physical barrier.11 Epithelial cells have been shown to express TLRs, secrete 
antimicrobial peptides, cytokines and chemokines, and even present antigen.11-13 In 
addition, innate immune recognition by the epithelial cell barrier largely determines the 
functional properties of resident tissue macrophages and dendritic cells, thus driving the 
outcome of antigen-specific immunity.11,14 While respiratory epithelia of many 
mammalian species have been studied in recent years and have been found to express 
TLRs, AMPs, cytokines and MHC class I and II molecules,11,13,15 equine immunity at the 
respiratory epithelial cell barrier remains poorly described. 
Investigation of this important area has been hindered by a lack of a suitable in 
vitro model. Conventional models of respiratory epithelial cell cultures were established 
by fully immersing cells in media.16,17 One limitation to this culture method is the loss of 
respiratory epithelial cell differentiation over time.18,19 To address this limitation, a 
biphasic hamster airway epithelial cell culture model provided a powerful new technique 
to culture airway epithelial cells that maintained characteristics of cell differentiation.20 
Airway epithelial cell culture models grown at the air-fluid interface (AFI) have since 
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been developed for other species as a tool to study allergy and infectious disease.21-23 
More recently, successful culture of differentiated equine bronchial epithelial cells 
cultured at the AFI has been described.24 Morphologically, respiratory epithelial cells 
cultured at the AFI appear to mimic the equine airway epithelium as a heterogeneous 
population of ciliated cells, basal cells, and secretory cells generating a pseudo-stratified 
mucociliary epithelium contrary to what is seen with respiratory epithelial cells cultured 
submerged.25 In addition, secretion of mucin proteins has been characterized in 
differentiated respiratory epithelial cell cultures grown at the AFI.24,25 Tight junction 
formation, characteristic of epithelial cells and responsible for creating a physical barrier, 
can be demonstrated by transepithelial electrical resistance (TEER) measurement.25 
Finally, these cultures have been demonstrated to support viral infection and 
replication.26,27 
Despite evidence that respiratory epithelial cells grown at the AFI mimic the 
equine airway epithelium morphologically, little information exists as to how these 
cultures perform immunologically. So far, toll-like receptor and antimicrobial peptide 
expression has only been described in human airway epithelial cells cultured at the AFI.28 
While constitutive cytokine expression has been demonstrated in respiratory epithelial 
tissues and conventional primary respiratory epithelial cell cultures,11 no such 
information is available for differentiated airway epithelial cells cultured at the AFI. The 
goals of this study were to establish baseline immunological characteristics in equine 
respiratory epithelial cells cultured at the AFI and compare them to the equine airway 
epithelium. In the future this model will be used study host immunity to respiratory 
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pathogens including EIV and EHV-1 and may open pivotal new avenues for the 




Animals, epithelial tissue collection, and processing 
Respiratory epithelium was collected from three horses with no apparent signs of 
respiratory disease. The horses consisted of a 2 year old mixed breed stallion, a 5 year old 
Morgan gelding, and an 8 year old Quarter Horse mare. Horses were humanely 
euthanized intravenously by administration of an overdose of 390 mg/mL of 
pentobarbital (Buthanasia) for medical reasons unrelated to any respiratory condition. For 
each horse, a large section of epithelium was collected from the larynx and two tracheal 
rings were collected from the upper, middle and lower trachea. Bronchial rings from the 
left and right primary bronchi were collected distal to the carina of the trachea. A large 
section of lung was pulled from the center of the right or left lobe. For RNA isolation, 
respiratory tissues were collected in cold phosphate buffered saline (PBS; Cellgro, 
Mediatech Inc., Manassas, VA) and 200 mg tissue sections were excised and snap-frozen 
in liquid nitrogen. For epithelial cell isolation, respiratory tissues were collected from the 
same locations in cold Dulbecco’s Modified Eagle Medium supplemented with Ham’s 
F12 nutrient mixture (DMEM/F12) (Gibco, Invitrogen, Carlsbad, CA) for further 
processing. Procedures and experimental protocols followed the animal care guidelines of 
the Animal Care and Use Committee, Colorado State University. 
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Isolation and culture of primary equine respiratory epithelial cells 
Isolation and culture of primary respiratory epithelial cells were performed as 
previously described.25 Briefly, equine epithelial tissues were washed in PBS to remove 
red blood cells. Following enzymatic digestion in 1.4% pronase (Roche Applied Science, 
Indianapolis, IN) and 0.1% deoxyribonuclease I (Sigma-Aldrich, St. Louis, MO), 
epithelial cells from each location were harvested using gentle agitation in calcium and 
magnesium free minimal essential medium for 48 hours. Epithelial cells were then 
incubated in a plastic uncoated petri dish for two hours to reduce fibroblast contamination 
by adherence. Isolated ERECs were stored in liquid nitrogen at a density of 2 million 
cells per cryovial until further use. For culture at the air-fluid interface, primary equine 
respiratory epithelial cells (ERECs) were seeded into Type IV collagen (Sigma-Aldrich) 
coated transwell cell culture wells (Costar, Corning, Fisher Scientific, Fair Lawn, NJ) in 
DMEM/F12, containing 2% Ultroser G (Pall Life Sciences, Pall Corp., Cergy, France), 
1% penicillin-streptomycin (Gibco, Invitrogen, Carlsbad, CA) and 0.5% amphotericin B 
(Biowhittaker, Walkersville, MD). ERECs were incubated in a 37°C, 5% CO2, 
humidified incubator until differentiated. Factors that determined the point of 
differentiation included tight junction formation, mucin production, and cilia 
development. A transepithelial electrical resistance (TEER) voltometer (EVOM, World 
Precision Instruments, Sarasota, FL) was used to determine the presence of tight 
junctions. A positive control for TEER measurements provided by the manufacturer was 
used for comparison. The presence of ciliated epithelial cells was assessed 
microscopically following formalin-fixation, paraffin-embedding, and routine 
hematoxylin and eosin staining. 
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RNA isolation and Polymerase Chain Reaction 
Total RNA was extracted from tissues through homogenization on ice using an 
Omni™ hand-held tissue homogenizer (Omni international, Kennesaw, GA) in TRIzol 
reagent (Invitrogen, Carlsbad, CA). RNA was isolated from fresh, uncultured ERECs or 
ERECs cultured at the AFI by adding 1mL TRIzol to a tube containing 1 x 106 cells per 
location, or directly onto the transwell insert, respectively. Total RNA was extracted from 
homogenized airway tissues, spleen, mesenteric lymph node, isolated, uncultured ERECs, 
and four-week epithelial cell AFI cultures using a Qiagen RNeasy Minikit (Qiagen, 
Hilden, Germany) following the manufacturers instructions and treated with 
deoxyribonuclease (Sigma-Aldrich, St. Louis, MO) to eliminate genomic DNA 
contamination. RNA isolated from spleen and mesenteric lymph node was used as 
positive control tissues for the mRNA expression of TLR9. RNA quality and quantity 
was determined using spectrophotometry. Reverse transcriptase PCR (RT-PCR) of 1µg 
of RNA was performed using the iScript ™ cDNA synthesis kit (Bio Rad, Hercules, CA) 
in a total volume of 20µl following the manufacturers recommended incubation 
conditions (5 min at 25°C, 30 min at 42°C, 5 min at 85°C). Controls consisting of 
reactions without the addition of reverse transcriptase were included for each sample to 
detect genomic contamination. All cDNA samples were stored at -20°C until further use. 
 For detection of TLR and AMP expression, sequence-specific primers were 
designed based on published and predicted equine DNA sequences from the NCBI 
database using Primer 3 Input software version 4.0 (http://frodo.wi.mit.edu/primer3/) 
(Table 2.1). For each reaction, 3 µl of cDNA was amplified in a 25 µl standard reaction 
using 20 µl Platinum PCR SuperMix (Invitrogen, Carlsbad, CA) and 2 µl of forward and 
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reverse primers at the following cycling conditions: 35 cycles of 94°C for 30 seconds, 
45°C for 30 seconds, and 72°C for 1 min. All reactions included β-actin as a 
housekeeping gene. PCR products were stained using EZvision Three™ fluorescent dye 
(Amresco, Solon, Ohio) and analyzed on a 2% agarose gel. PCR reaction products were 
purified for sequencing using Phenol:Chloroform (Fisher Scientific, Fair Lawn, NJ) 
followed by standard ethanol precipitation and sequenced at the Proteomics and 
Metabolomics Core Facility at Colorado State University using an ABI 3130 Genetic 
Analyzer. All sequenced PCR products were confirmed using DNASTAR Lasergene 
software (DNASTAR, Inc, Madison, WI). 
 
Table 2.1. Primer design (5’ to 3’) for respective equine toll-like receptors and 
antimicrobial peptides. 
Name Forward Reverse Product 
(bp) 
Reference 
TLR1 actttgcccaccacaatctc ccaaaagcagcaacagtgaa 275  
TLR2 acggcagctgtgaaaagtct cctgaaccaggaggacgata 213  
TLR3 acctcccagcaaacataacg ctggaggtccaaaatttcca 179  
TLR4 gacgactcaggaaagccttg cacaatgcctggtatgttgc 194  
TLR6 tcagaccccattagacagcc caagtaccttgaccctggga 640  
TLR7 atcttgacgcctctcatgct ggaatgtccgtcaaatgctt 249  
TLR8 ggaatctgacacggcttgat agaaggcaggtgggaaatct 272  
TLR9 gtgactggctacctggcaagac tggttatagaagtggcggttgtcc 373 29 
TLR10 gcttgccccaaagtattcaa aagtggaggcagcagaaagt 484  
β-actin ggcatcctgaccctcaagta ggggtgttgaaggtctcaaa 203  
β-defensin 1 ttaagctcaccagccatcag ctgtcacagcagtttctccg 243  
MxA agagtcctcgatggcagaaa tgagacagagagcccgattt 298               30 
2’5’ OAS agacagcgaggacgacactt cttctcaccaggcacacaga 444 31 






Epithelial cell purity in both freshly isolated ERECs and 4 week ERECs cultured 
at the AFI were estimated by permeabilizing with 1% Saponin (Fluka, Biochemika, 
Sigma-Aldrich, St. Louis, MO) and staining the cells for two hours at room temperature 
with a pan-anticytokeratin antibody (Zymed, Invitrogen, Carlsbad, CA; 5 µg/ml) 
followed by a secondary fragment goat anti-mouse IgG antibody conjugated with 
fluorescein (3 µg/mL) (Jackson Laboratories, West Grove, PA) and analyzed using 
FACS. Expression of TLRs 3 and 9 in freshly isolated ERECs and 4 week ERECs 
cultured at the AFI were determined by incubating 1 x 106 cells for two hours at room 
temperature in 5µg/ml of either mouse anti-human TLR 3 or TLR 9 conjugated with 
Alexa-Fluor 647 (Imgenex, San Diego, CA). MHC-I and MHC-II expression was 
examined using anti equine MHC-I and MHC-II (CVS 22 and CVS 10) monoclonal 
antibodies.32 One million cells were incubated with either CVS10 or CVS22 for 45 
minutes at 4°C followed by incubation with a secondary fragment goat anti-mouse IgG 
antibody (Jackson Laboratories, West Grove, PA) conjugated with allophycocyanin 
(0.1µg/mL) for 30 minutes at room temperature and analyzed by flow cytometry. 
 
Cytokine/Chemokine Analysis 
Cytokines to be examined were selected based on what has been reported for 
epithelial cytokine panels in the literature12,33 in addition to those important in innate 
homeostatic regulation and anti-viral defense. These cytokines included IL-1, IL-6, IL-8, 
IL-10, IL-12, TNF-α, TGF-β, IFN-α, IFN-β, GM-CSF and MCP-1. Cytokine and 
chemokine expression was compared between epithelial tissues, freshly isolated, 
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uncultured ERECs, and ERECs grown at AFI. RNA was isolated and 1µg of RNA was 
reverse transcribed as described above. Samples of cDNA and their respective no-RT 
controls were analyzed using previously established real-time PCR assays 
(http://www.ca.uky.edu/Gluck/HorohovDW_EIRClonedCytokines.asp). A standard 
housekeeping gene (β-gus) was used as an internal control. Relative expression of each 
gene was determined by calculating the 2(-Delta Delta C(T)) values using  average delta 
CT values of equine airway tissue samples as calibrators.34 
 
Statistical Analyses 
All values for the expression MHC-I, MHC-II, TLR3, and TLR9 determined by 
FACS staining and analyses are expressed as mean percent ± standard errors of the mean 
(SEM). Mann-Whitney tests were used to determine differences in the mean percent 
expression of MHC-1, MHC-II, TLR3, and TLR9 between isolated ERECs, and ERECs 
cultured at the AFI. Kruskal-Wallis rank sum tests were used to determine differences in 
the mean percent expression of MHC-I, MHC-II, TLR3, and TLR9 from FACS staining 
between five different locations of the equine respiratory tract in isolated ERECs, and 
EREC AFI cultures. Means were considered significantly different at P ≤ 0.05. 
Kruskal-Wallis rank sum tests were also used to evaluate differences in the 
mRNA cytokine and chemokine expression from real-time PCR between equine airway 
tissue and ERECs cultured at the AFI after four weeks. Differences in mean relative 
expression of cytokines and chemokines between EREC AFI cultures and equine airway 






Equine respiratory epithelial cell differentiation 
Differentiation of respiratory epithelial cells was defined as cultures exhibiting 
ciliated epithelial cells, mucin production, and tight junction formation. AFI cultures of 
epithelial cells from locations throughout the respiratory tract of three horses displayed 
consistent differentiation by week four. Representative images from hematoxylin and 
eosin stains of the larynx, upper trachea, lower trachea and bronchus are shown in figure 
2.1. Cultures featured ciliated epithelial cells, non-ciliated epithelial cells and basal cells. 
Additionally, mucin production was clearly visible on the apical surface of the cells and 
tight-junction formation was demonstrated by mean TEER measurements of 267 Ω-cm2 






Figure 2.1. Hematoxylin and eosin staining showing morphological appearance of 
ciliated pseudostratified ERECs cultured at the AFI from the (A) larynx, (B) upper 
trachea, (C) lower trachea, and (D) bronchus. Images from middle trachea are not shown 
but mirrored images from the other locations. 
 
Expression of TLRs and AMPs in equine airway tissues 
Expression mRNA specific for TLRs 1-4, 6-8 and 10 and the antimicrobial 
peptides beta-defensin 1, MxA, the 2’5’ oligoadenylate synthase-like (2’5’ OAS) 
molecule and lactoferrin was detected in homogenized airway tissues of the larynx, 
upper, middle, and lower trachea as well as the bronchus of three different horses. A 
representative gel for these results is shown in figure 2.2A. In addition, expression of 
equine TLR9 mRNA was detected in airway tissue epithelium from all locations of the 
respiratory tract, as well as in spleen and mesenteric lymph node (Figure 2.2B). However, 
the band intensity for TLR9 was low for all locations of the airway epithelium as well as 
the spleen tissue compared to mesenteric lymph node tissue. Sequencing of PCR products 
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confirmed the identities of all respective TLRs and AMPs through comparison of each 
respective sequence to those published in the database of the National Center for 
Biotechnology Information. 
 
Immunological characteristics of isolated ERECs 
TLR and AMP expression was evaluated in epithelial cells harvested from tissue 
epithelium to evaluate the effects of enzymatic digestion and processing on their 
immunological properties. There were no differences in TLR and AMP expression 
between equine airway epithelium and isolated ERECs, therefore, PCR gels from both 
equine airway epithelial tissue and isolated ERECs can be depicted in Figure 2.2. In 
addition to mRNA expression, TLR3 and TLR9 protein expression was also 
demonstrated throughout several locations of the respiratory tract in isolated epithelial 






Figure 2.2. A) Top: mRNA expression of TLRs 1-4, TLRs 6-8 and TLR 10 in equine 
bronchus epithelium; bottom: mRNA expression of beta-defensin 1, MxA , 2’5’ OAS and 
lactoferrin. Beta-actin was the housekeeping gene used as an internal control. Results 
were consistent for all locations of the respiratory tract in three horses; therefore, the gels 
depicted are representative. B) mRNA expression of TLR 9 in the epithelial tissue of the 
larynx, upper, middle, and lower trachea, as well as the bronchus of one horse. Spleen 
and mesenteric lymph node were incorporated as controls. Results were consistent for all 








Table 2.2. Comparison of TLR3 and TLR9 between isolated ERECs and ERECs cultured 
at the AFI throughout the respiratory tract using FACS staining and analysis. Data is 
shown as mean percent of cells (± SEM) that stain positive for TLR3 and TLR9.  
 TLR9 TLR3 
 Isolated ERECs EREC AFI Isolated ERECs EREC AFI 
Larynxab (n=3) 28.2 ± 9.3 37.9 ± 6.9 11.4 ± 5.7 39.9 ± 8.8 
Upper tracheab (n=3) 15.3 ± 4.4 37.2 ± 7.6 2.0 ± 1.2 35.3 ± 15.6 
Middle trachea (n=4) 24.7 ± 4.8 34.6 ± 7.5 5.0 ± 1.7 26.9 ± 11.9 
Lower trachea (n=4) 28.1 ± 8.4 32.7 ± 6.4 7.0 ± 2.3 32.2 ± 10.0 
Bronchusa (n=3) 17.6 ± 14.7 40.2 ± 0.6 5.9 ± 4.3 35.1 ± 6.0 
aP<0.05 is where significant differences were observed in the expression of TLR3 
between isolated ERECs and EREC AFI cultures. 
bP<0.05 is where significant differences were observed in the expression of TLR9 
between isolated ERECs and EREC AFI cultures. 
No differences were observed in the expression of TLR3 and TLR9 between different 
locations of the equine respiratory tract. 
 
 
Lastly, MHC-I and MHC-II expression in isolated ERECs from throughout the 
equine respiratory tract is shown in Table 4. MHC-I was expressed in the majority of 
ERECs isolated from the respiratory tract from all locations evaluated. This ranged, on 
average, from 86.7% ± 0.7% MHC-I expression in isolated epithelial cells of the 
bronchus to 96.7% ± 0.6% MHC-I expression in isolated epithelial cells of the larynx 
(Table 2.3). A similar pattern was observed in the expression of MHC-II where, on 
average, MHC-II expression in freshly isolated, uncultured ERECs ranged from 59.6% ± 









Table 2.3. Comparison of MHC-I and MHC-II between isolated epithelial cells and 
epithelial cells cultured at the AFI throughout the respiratory tract (n=3) using FACS 
staining and analysis. Data is shown as mean percent of cells (± SEM) that stain positive 
for MHC-I and MHC-II. 
 MHC-I MHC-II 
 Isolated ERECs EREC AFI Isolated ERECs EREC AFI 
Larynxab 96.7 ± 0.6 56.6 ± 13.2  81.0 ± 5.3 20.6 ± 2.9 
Upper tracheaab 97.4 ± 0.8 49.4 ± 4.8  72.8 ± 16.3 9.2 ± 4.3 
Middle tracheaab 92.2 ± 2.8 57.8 ± 2.8 76.8 ± 6.1 17.4 ± 7.5 
Lower tracheaab 88.0 ± 1.4 63.2 ± 3.5 64.9 ± 3.1 18.4 ± 9.5 
Bronchusab  86.9 ± 0.7 53.6 ± 6.8 59.6 ± 6.8 19.4 ± 12.8 
aP<0.05 is where significant differences were observed in the expression of MHC-I 
between isolated ERECs and EREC AFI cultures.  
bP<0.05 is where significant differences were observed in the expression of MHC-II 
between isolated ERECs and EREC AFI cultures. 
No differences were observed in the expression of MHC-I and MHC-II between different 
locations of the equine respiratory tract.  
 
 
Immunological characteristics of ERECs cultured at the AFI 
EREC AFI cultures retained several of the same immunological properties 
characterized in equine airway tissues and isolated epithelial cells. Consistent mRNA 
expression was demonstrated for TLRs 1-4, TLR6 and TLR7 of three different horses 
(Figure 2.3A) and is summarized in Table 2.4. Interestingly, mRNA expression of TLR8, 
TLR9 and TLR10 was not detected despite the fact that moderate band intensity of TLR8 
and TLR10 was found in the airway epithelial tissues. All antimicrobial peptides 
characteristic to airway tissues were detected in the AFI cultures after four weeks with 







Figure 2.3. A) mRNA expression of TLRs 1-4, 6 and 7 in bronchus epithelial cells 
cultures at the air-fluid interface after 4 weeks and B) mRNA expression of β-defensin, 
MxA, and 2’5’OAS in bronchus epithelial cells cultures at the air-fluid interface after 4 
weeks. Gel picture is representative for other locations of the respiratory tract cultured at 







Table 2.4. Comparison of mRNA expression of TLRs and AMPs in equine epithelial 
tissue, isolated ERECs, and EREC AFI cultures using conventional PCR where n=3. 
 Epithelial tissues Isolated ERECs EREC AFI cultures 
TLRs TLRs 1-4, 6-10 TLRs 1-4, 6-10 TLRs 1-4, 6, 7 
AMPs β-def 1, MxA, 2’5’ OAS, lactoferrin 
β-def 1, MxA, 2’5’ OAS, 
lactoferrin 
β-def 1, MxA, 





Expression of TLR3 and TLR9 protein was also demonstrated in epithelial cells 
cultured at the AFI throughout the respiratory tract using FACS (Table 2.2). Interestingly, 
TLR9 protein was detected using FACS staining and analysis in EREC AFI cultures 
throughout the respiratory tract despite the loss of detection for TLR9 mRNA (Figure 
2.3A). While no differences were observed in the expression of TLR9 between isolated, 
uncultured ERECs and ERECs cultured at the AFI after four weeks, significant 
differences were found in the expression of TLR3 between isolated, uncultured ERECs, 
and EREC AFI cultures from the upper trachea (P=0.023) and the bronchus (P=0.034). 
Differences were also observed in the expression of MHC-I and MHC-II between 
isolated, uncultured ERECs, and ERECs grown at the AFI from different locations of the 
equine respiratory tract with the exception of the upper trachea (Table 2.3). After four 
weeks of in vitro growth conditions, MHC-I expression in EREC AFI cultures ranged, on 
average, from 50.0% ± 8.3% in the upper trachea to 63.2% ± 3.5% in the lower trachea 
(Table 2.3). Differences in MHC-II expression between isolated ERECs and EREC AFI 
cultures were even more pronounced. MHC-II expression in EREC AFI cultures ranged 
from 6.4% ± 5.6% in the upper trachea to 20.6% ± 2.9% in the larynx (Table 2.3). 
 
 
Equine airway cytokine and chemokine expression 
We found that after four weeks of in vitro growth conditions, ERECs cultured at 
the AFI expressed IL-8, IL-10, TNF-α, TGF-β, GM-CSF, and IL-6, but not IL-1, IL-12, 
IFN-α, IFN-β, or MCP-1 (Figure 2.4A). While constitutive cytokine expression was 
evaluated in EREC AFI cultures from three different horses, TNF-α and IL-10 were 
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detected in only two of the three cultures examined, however, the culture not secreting 
TNF-α and the culture not secreting IL-10 were not from the same horse. No significant 
differences were observed in the expression of GM-CSF, IL-10, and TGF-β, between 
equine airway tissue, and ERECs cultured at the AFI after four weeks. In contrast, 
significant differences (P ≤ 0.05) were observed in the mRNA expression of IFN-α, IFN-
β, IL-1, IL-12, IL-6, IL-8, MCP-1, and TNF-α. 
Intriguingly, mRNA cytokine and chemokine expression in isolated, uncultured 
ERECs was higher than both the equine respiratory epithelial tissue and EREC AFI 
cultures for all cytokines and chemokines evaluated with the exception of IFN-α, IL-12, 









Figure 2.4. mRNA cytokine and chemokine expression from real-time PCR in A) ERECs 
cultured at the AFI compared to equine respiratory tissues and B) isolated ERECs where 







Our study is the first to describe the development of a novel equine respiratory epithelial 
cell culture AFI system that is morphologically similar to the equine airway epithelium, 
and retains several immunological characteristics important in host immune defense after 
four weeks of in vitro growth conditions. We examined the same immunological 
characteristics in equine airway epithelium, freshly isolated epithelial cells and 4 week 
old equine respiratory epithelial cell cultures (ERECs) grown at AFI as a basis for 
comparison. The results of our study demonstrate that equine respiratory epithelial cell 
cultures grown at AFI retain mRNA expression of TLRs 1-4, and 6-10 and express TLR3 
and TLR9 protein at similar levels seen in freshly isolated epithelial cells from the same 
location. In addition, we could demonstrate expression of several antimicrobials 
including β-defensin, MxA and 2’5’OAS that have the potential to serve as a defense 
mechanism from viral invasion. Lastly, we were able to show expression of both MHC-I 
and MHC-II, molecules critical for antigen presentation. 
While the loss of TLR9 mRNA was not unexpected considering the low band 
intensity seen in the equine respiratory epithelium tissue samples and the isolated 
epithelial cells, it was interesting that TLR9 expression could still be demonstrated in 
EREC AFI cultures using FACS. In human respiratory epithelial cell lines and fully 
differentiated primary respiratory epithelial cells cultured at the AFI, TLR9 expression is 
demonstrated at low levels using quantitative real-time PCR.35 It is possible that the 
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differences between our mRNA expression results and protein expression results are due 
to differences in assay sensitivity. 
The loss of TLR8, TLR10 and lactoferrin mRNA expression is interesting and 
similar observations were made in a study in human lung epithelial cells that showed 
absence of TLR7 or TLR8.36 A later study in human fallopian tube epithelial cells 
demonstrated expression of TLRs 1-9 but not 10.37 As ERECs cultured at the AFI are 
grown in vitro for four weeks, a reduction or loss of antigenic stimulation could account 
for the loss of expression of these molecules. Previous studies have demonstrated the 
activation and up-regulation of TLRs using synthetic and non-synthetic immune 
modifiers.36,38 Whether the introduction of TLR agonists restore TLR8 or TLR10 
expression in the EREC AFI model needs to be examined.  
Intriguingly, we also found a reduction of both MHC-I and MHC-II in ERECs 
cultured at the AFI after four weeks when compared to freshly isolated epithelial cells. 
This is an interesting observation, particularly for MHC-I, which is normally expressed 
on all nucleated cells. In the airway epithelium, the surface expression of MHC-I and 
MHC-II molecules is tightly regulated by cytokines, particularly interferons (IFN). 
Additionally, cytosolic peptidases are known to regulate MHC-I peptide production and a 
number of studies have demonstrated that over expression of the endopeptidase EP24.15 
is primarily responsible for degrading MHC-I peptides resulting in the suppression of 
surface MHC-I expression.39 However, this study demonstrated that IFN-γ treatments 
(10ng/ml) can restore MHC-I surface expression in EP24.15-overexpressing cells.39 In 
the equine airway epithelium, major sources of IFN-γ include natural killer cells and T-
cells, whereas fibroblasts, dendritic cells and leukocytes are major sources of IFN-α and 
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IFN-β. While IFN-γ production by EREC AFI cultures was not measured, IFN-α and 
IFN-β were examined using quantitative real-time PCR and were not detected in these 
cultures after four weeks of in vitro growth conditions suggesting that the lack of 
underlying immune cells and IFNs in the AFI model may account for the reduction of 
MHC-I, MHC-II or both.  
As cytokines and chemokines are paramount in the regulation of host immunity, 
cytokine and chemokine mRNA expression was examined using real-time PCR in 
ERECs cultured at the AFI, isolated ERECs, and equine airway tissue. While constitutive 
cytokine expression in EREC AFI cultures was reduced when compared to whole tissues, 
constitutive expression of several cytokines was still demonstrated in the AFI model 
including those important in maintaining airway inflammation homeostasis (IL-10 and 
TGF-β).40 The production of TNF-α, IL-8, IL-6, and GM-CSF was not unexpected, as 
previous literature has demonstrated secretion of these cytokines by airway epithelial 
cells.11,41,42 Secondly, IL-12, IFN-α, and IFN-β were not detected in EREC AFI cultures 
after four weeks of in vitro growth conditions. However, epithelial cells have not been 
implicated as a major source for these cytokines. In contrast, the loss of IL-1 and MCP-1 
in the EREC AFI cultures is remarkable as epithelial cells are robust producers of IL-1 
and have been also known to produce MCP-1.43 TLRs 1, 2, 4, and 6 are known to signal 
the production of IL-1 through NF-κB4 and these TLRs were detected in our EREC AFI 
cultures. However, an earlier study found that unstimulated thymic epithelial cells 
produced negligible amounts of IL-1α and IL-β44 suggesting ERECs cultured at the AFI 
might produce IL-1 upon stimulation. Therefore, a lack of antigenic stimulation and 
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underlying immune cells would likely account for the low expression levels of cytokines 
and chemokines in the EREC AFI model.  
The finding that isolated, uncultured ERECs consistently produced higher levels 
of cytokines and chemokines with the exception of IFN-α, IL-12 and MCP-1 compared 
to EREC AFI cultures and equine airway tissues is interesting and suggests that these 
cells may have been stimulated during processing through enzymatic tissue digestion but 
may decrease following cell culture in vitro. 
In summary, we have demonstrated, through the comparison of six different 
locations of the respiratory tract, consistent patterns in the expression of toll-like 
receptors, antimicrobial peptides, MHC-I, and MHC-II for ERECs cultured at the AFI, 
isolated ERECs, and equine airway epithelial tissue. Furthermore, we have confirmed 
that ERECs cultured at the AFI are morphologically similar to the equine airway epithelia 
and retain a number of key immunological properties after four weeks of standard 
laboratory growth conditions. While we can demonstrate that ERECs cultured at the AFI 
are immunologically competent, it appears that some of the immunological properties are 
altered, most likely as a consequence of sterile in vitro growth conditions and presumably 
as a temporary state that could be remedied by adding antigenic stimuli and/or underlying 
immune cells. In the future, this EREC-AFI model will be used as a tool to study equine 
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The purpose of this study was to evaluate whether an equine-derived contemporary 
canine H3N8 influenza A virus remained capable of infecting and transmitting among 
ponies. Twenty influenza virus seronegative ponies aged 12 to 24 months were used in 
this study. Two groups of 5 ponies were inoculated by aerosol exposure with 107 TCID50 
dose per pony of A/Canine/Wyoming/86033/07 (Ca/WY) for one group and, serving as a 
positive control, a contemporary A/Eq/CO/10/07 (Eq/CO) for the second group. As a 
 51 
negative control, four ponies were mock-inoculated. To evaluate the potential for virus 
transmission to in-contact horses, three ponies were introduced two days after aerosol 
exposure and housed with the inoculated animals as sentinels. Clinical signs, nasal virus 
shedding, and serological responses to inoculation were monitored in all ponies for up to 
21 days after virus challenge. Growth and infection characteristics of challenge isolates 
were examined using MDCK cells and primary equine and canine respiratory epithelial 
cells. Ponies inoculated with Ca/WY demonstrated mild changes in clinical appearance 
compared to the Eq/CO inoculated ponies. Additionally, Ca/WY produced significantly 
lower M gene copy numbers in nasal secretions as well as significantly lower systemic 
antibody responses in ponies than Eq/CO. Lastly, the Ca/WY isolate did not transmit to 
the sentinel ponies. Compared to the equine H3N8 influenza isolate, inoculation of ponies 
with the contemporary canine H3N8 isolate resulted in mild clinical disease, minimal 
nasal virus shedding and weak systemic antibody responses. Taken together, these results 












TCID50 50% tissue culture infectious dose 
EIV  Equine influenza virus 
CIV  Canine influenza virus 
HA  Hemagglutinin 
NA  Neuraminidase 
M  Matrix 
Ca/WY A/Canine/Wyoming/86033/07 
Eq/CO  A/Equine/Colorado/10/07 
REC  Respiratory epithelial cell 
CREC  Canine respiratory epithelial cell 
EREC  Equine respiratory epithelial cell 
HI  Hemagglutination inhibition 
MDCK Madin-Darby canine kidney 
MEM  Minimal essential medium 
RT-PCR Reverse transcriptase polymerase chain reaction 
MOI  Multiplicity of infection 
BSA  Bovine serum albumin 









Infections with equine influenza virus have remained a serious health and economic 
problem in horses worldwide.1 The immune response induced by influenza virus 
infection protects against re-infection with the same or antigenically similar virus strain. 
However, as influenza virus undergoes frequent antigenic change (“antigenic drift”), 
protection provided by the host’s immunity may be reduced as the virus becomes more 
antigenically distinct.2 The occasional introduction of gene segments or entire viruses 
from other host species also adds to the vast genetic and antigenic diversity of influenza 
viruses.3 Although horses have often been regarded as isolated or “dead-end” hosts for 
influenza cross-species transmission,3,4 the transmission and subsequent maintenance of 
an equine-lineage H3N8 virus to dogs in the U. S. highlights the fact that the barrier for 
influenza viruses emerging from horses is not absolute.5 
Since their first isolation in 2004, the canine influenza viruses have continued to 
evolve genetically. Phylogenetic analyses of the HA and NA genes of contemporary 
canine isolates indicate that the canine viruses since have segregated from the equine H3 
“Florida lineage” as a distinct sub-lineage.5,6 Five amino acid residues at positions 54, 83, 
222, 328 and 483 of the H3 HA appear to differentiate the canine isolates from 
contemporary equine H3N8 viruses.5,6 Although the biological significance of these 
amino acid substitutions remains unclear, from a host immunological perspective, the 
asparagine to lysine mutation at position 54 and possibly the serine to asparagine 
substitution at position 83 are of particular interest as they are located in antibody binding 
 54 
regions of the HA protein.7,8 The potential importance of these amino acid residues is 
highlighted by the finding that residue 83 has been shown to be involved in antigenic 
drift in human H3 viruses.9,10 Similarly, the N54K substitution occurred in the center of 
an N-linked glycosylation motive and as a consequence, the posttranslational 
glycosylation of the protein may be altered,11 thereby resulting in the reduced 
accessibility of the epitope.12,13 In light of these findings, the mutations at residues 54 and 
83 have been hypothesized to facilitate viral escape from neutralization by preexisting 
antibodies.8 As asparagine at position 54 is highly conserved in equine and other non-
canine H3N8 influenza viruses, including the strains used for production of equine 
vaccines currently marketed in the U.S., we hypothesized that the canine isolates could 
represent an emerging disease threat to horses provided that they have maintained the 
ability to infect horses. Moreover, the finding that dogs could represent a source of 
infection for horses would have importance for the development and implementation of 
biosecurity protocols on equine farms. 
Despite the fact that cross-species transmission of influenza A viruses occurs 
relatively frequently, such newly introduced viruses are only rarely maintained in the new 
host species.3 While it is not known what properties are necessary to allow a virus to 
form a stable lineage, the viral HA is considered to play a key role in influenza species-
specificity.14,15 Given the importance of the HA protein in limiting transmission of 
influenza A viruses among species, it is unclear whether the genetic divergence of the 
canine and equine H3 viruses, including the five amino acid mutations in the HA protein, 
has resulted in a reduction of infectivity of canine-lineage influenza in horses. To 
examine whether an equine-derived canine H3N8 influenza A virus maintained its 
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infectivity in equines, we inoculated ponies by aerosol exposure with a canine influenza 
isolate (Ca/WY). Serving as positive controls, a second group of ponies was inoculated 
with a contemporary equine H3N8 virus (Eq/CO). Lastly, as efficient horse-to-horse 
transmission is an important requirement for virus maintenance, we also studied the 
horizontal spread of the virus to influenza naïve sentinel ponies housed in direct contact 
with the inoculated animals. Growth and infection characteristics of Ca/WY and Eq/CO 
were also examined in MDCK cells and primary canine and equine respiratory epithelial 






Twenty ponies aged 12 through 24 months were purchased from a commercial source 
and shown to be serologically negative for EIV by enzyme-linked immunosorbent assay20 
and hemagglutination inhibition assay as previously described.21 The animals were 
clinically healthy and in good body condition and were maintained in accordance with 
guidelines of the Colorado State University Research and Animal Resources Committee. 
They were fed a diet of hay and a pelleted vitamin and mineral concentrate, and group-
housed outdoors in pens in three geographically separate locations with access to water 
and shelter. Prior to initiation, this study was reviewed and approved for conduct by the 




The contemporary H3N8 canine influenza virus Ca/WY and the contemporary H3N8 
equine influenza virus Eq/CO were isolated during field outbreaks of EIV and CIV 
respectively. EIV infection was confirmed at an equine boarding facility housing 42 
horses in July 2007. Clinical signs of equine influenza consisting of fever, coughing, and 
nasal discharge had first been observed among two horses that had returned from a show 
three days earlier. Subsequently, clinical disease spread rapidly among the remaining 
horses on the property. Nasal shedding of influenza virus was diagnosed in four of 32 
horses tested by real-time RT-PCR. EIV was isolated on first passage in embryonated 
chicken eggs from two of the four real-time RT-PCR positive nasal swab specimens and 
designated as Eq/CO. After the positive diagnoses, serum samples were collected from 32 
of 42 horses. A convalescent serum sample was taken from all 32 horses 14 days later. 
Testing of the paired serum samples for influenza-specific antibodies by HI assay 
demonstrated seroconversion in 20 of 32 (62.5%) horses tested. The contemporary canine 
virus was isolated that same year. In mid February 2007, an outbreak of respiratory 
disease occurred in dogs at a humane shelter. The outbreak involved all 27 dogs housed 
at the shelter at the time. Clinical signs observed included fever, lethargy, cough, and 
nasal discharge. Nasal swab and serum samples were collected from 18 of 27 dogs. 
Paired acute- and convalescent-phase serum samples were available for collection from 
13 dogs and were tested for CIV-specific antibodies by HI assay. Twelve of 18 nasal 
swab samples tested positive for CIV by real-time RT-PCR and virus was isolated from 
three dogs on first passage in embryonated chicken eggs and designated as Ca/WY. Of 
the paired serum samples tested, 13 (100%) dogs showed seroconversion. 
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Genetic characterization and growth characteristics of viruses   
Both Ca/WY and Eq/CO were passaged three times in MDCK (American Type Culture 
Company, Manassas, VA) cells grown in MEM (Gibco, Invitrogen, Carlsbad, CA) as 
previously described.21 To rule out introduction of spurious mutations during cell culture 
passage, the full-length protein coding regions of all eight gene segments of Eq/CO and 
Ca/WY from allantoic fluid (pre cell culture passage) and 3rd passage MDCK stocks 
(used to inoculate ponies) were amplified by RT-PCR. The sequences of the amplified 
genes were determined by direct cycle sequencing (BigDye Terminator Cycle 
Sequencing Ready Reaction Kit, Perkin-Elmer Applied Biosystems). Sequence 
comparisons at the nucleotide and deduced amino acid levels were made using clustal 
analysis (http://align.genome.jp) and commercially available software (Lasergene, 
DNASTAR, Inc. Madison, WI). The phylogenetic relationships among the HA and NA 
genes of the virus isolates and selected reference strains were estimated from their 
nucleotide sequences by maximum parsimony with bootstrap analysis with a 
commercially available software program (PAUP 4.0 Macintosh beta version 10; Sinauer 
Associates, Inc., Sunderland, MA). Phylogenetic analyses of the HA and NA genes 
confirmed that Ca/WY clustered with the canine isolates and Eq/CO clustered with the 
contemporary equine viruses, placing them into the previously described canine and 
equine sub-lineages of the equine H3 “Florida lineage”.5,6 Moreover, amino acid 
sequence analysis of the HA genes of Ca/WY and Eq/CO verified the presence of five 
amino acid substitutions that differentiate the equine from the canine H3 consensus 
sequence.5,6 
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To characterize virus growth, one-step growth curves were performed in MDCK cells as 
previously described22 as well as in primary CRECs and ERECs grown at an air-fluid 
interface. Briefly, MDCK cells were grown in 35 x10 mm tissue culture plates and 
infected at an MOI of 10 TCID50/cell with either Ca/WY or Eq/CO. After 1 hr of 
adsorption, the inoculum was removed and 2 mLs of MEM containing 0.5% BSA (Fisher 
Scientific, Fair Lawn, NJ), penicillin-streptomycin (Gibco, Invitrogen, Carlsbad, CA), 
amphotericin B (Biowhittaker, Cambrex Bioscience, Walkersville, MD) and tolylsulfonyl 
phenylalanyl chloromethyl ketone (TPCK)-treated trypsin (1 µg/mL) (Worthington 
Biochemical Corp, Lakewood, NJ) was added. Supernatants were harvested at 2, 3, 4, 5, 
6, 7, 8, 10, 12, 14, 16, 20, and 24 hrs after infection and frozen at -80ºC until analysis by 
quantitative real-time RT-PCR. Isolation, culture and estimation of purity of primary 
RECs were performed as previously described.16,23 Briefly, RECs were isolated from 
fresh canine and equine trachea by enzymatic digestion using 1.4% pronase (Roche 
Applied Science, Indianapolis, IN) and 0.1% deoxyribonuclease I (Sigma-Aldrich 
Chemical Co., St. Louis, MO) in calcium and magnesium free MEM for 48 hours. After 
digestion, epithelial cells were harvested and incubated on an uncoated petri dish for two 
hours to reduce fibroblast contamination. Epithelial cell purity was estimated by ICC 
using a pan-anticytokeratin antibody (5 µg/ml) (Zymed, Invitrogen, Carlsbad, CA) and 
analyzed by flow cytometry. Primary CRECs and ERECs were seeded into Type IV 
collagen (Sigma-Aldrich Chemical Co., St. Louis, MO) coated transwell cell culture 
wells (Costar, Corning, Fisher Scientific, Fair Lawn, NJ) and cultured at the air-fluid 
interface in DMEM/F12 (Gibco, Invitrogen, Carlsbad, CA), 2% Ultroser G (Pall Life 
Sciences, Pall Corp., Cergy, France), penicillin-streptomycin and amphotericin B until 
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confluent. Primary cells were washed with DMEM/F12 to remove mucin and wells were 
infected in duplicate at an MOI of 10 with either Ca/WY or Eq/CO. After 2 hrs of 
adsorption, the inoculum was removed and replaced with fresh maintenance media. 
Alliquots of media were collected at 3, 4, 5, 6, 8, 12, 16 and 24 hours after infection and 
stored at -80 until real-time PCR analysis. Influenza M gene copy numbers in the cell 
culture media were determined by use of a quantitative real-time RT-PCR assay, as 
previously described.24,25 In addition, the presence of virus antigen was determined by 
ICC using a mouse anti-nucleoprotein monoclonal antibody (68D2) (courtesy of M. 




Ponies were randomly assigned to two groups of eight (primary inoculated ponies [n=5] 
and sentinel ponies [n=3]) and one group of four ponies (controls), respectively. For the 
duration of the experiment, each group was housed separately to prevent cross-
contamination. Physical examination and clinical scoring was conducted on all ponies 
throughout the course of the experiment at the same time as collection of serum and nasal 
swab samples daily from 2 days prior to inoculation and 14 days after inoculation 
(primary inoculated and control ponies), and daily from 2 days prior to 21 days after 
group introduction (sentinel animals). Clinical scoring was performed as previously 
described.26 Briefly, animals were observed for 20 min each day to assess their general 
appearance (attitude, food intake, and respiration were quantified on a scale of 0 to 1, 
with 0 indicating a clinically normal animal and 1 indicating an abnormal finding), 
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coughing (with 0 indicating that no cough is present, 1 indicating coughing once during 
observation, and 2 indicating coughing twice or more during observation), nasal 
discharge (with 0 indicating no discharge, 1 indicating serous discharge, 2 indicating 
mucopurulent discharge, and 3 indicating profuse mucopurulent nasal discharge), and 
rectal temperatures. Two days prior to inoculation, pre-inoculation nasal swab (sterile 
Dacron polyester tipped applicators, Hardwood Products Company LLC, Guilford, ME) 
samples and serum samples were collected. On day 0 of the experiment five ponies in the 
challenge groups were sedated by intravenous administration of 5 µg/kg of body weight 
of detomidine (Dormosedan® (10mg/mL), Pfizer, Kalamazoo, MI) and 0.05 mg/kg of 
body weight of butorphanol (Torbugesic® (10mg/mL), Fort Dodge, Fort Dodge, IA) and 
inoculated with either Eq/CO or Ca/WY at 107 TCID50 by aerosol inhalation as 
previously described.27 Four ponies were mock inoculated to serve as uninfected controls. 
On day 2 post inoculation, three influenza seronegative ponies were introduced to each of 
the virus inoculated groups and housed together with the inoculated ponies as sentinels 
throughout the remainder of the experiment. At daily intervals after inoculation, nasal 
swabs were obtained from each animal. The swabs were placed in 1 ml of viral transport 
medium containing phosphate-buffered saline, 0.5% BSA, and the antimicrobials 
penicillin-streptomycin, nystatin (Sigma-Aldrich Chemical Co, St Louis, MO), and 
gentamicin (Gibco, Invitrogen, Carlsbad, CA) and stored at -80ºC until further analysis. 





Evaluation of virus shedding 
Matrix gene copy numbers in nasal swab specimens were determined by use of a 
previously established quantitative real-time RT-PCR assay.24,25 Briefly, from each nasal 
swab sample, RNA was extracted from 140 µl of viral transport medium using a 
commercial RNA extraction kit (QIAamp® Viral RNA Mini Kit, QIAGEN, Hilden, 
Germany) according to the manufacturer’s instructions. One-tube real-time RT-PCR 
assay was performed using the following cycling conditions: 10 min 52°C, 5 min at 
95°C, 45 cycles of 10 sec at 95°C and 45 sec at 68.4°C. Each nasal swab sample was run 
in duplicates. Negative controls included with each assay consisted of water and neat 
transport medium. The positive control consisted of 101 TCID50 of A/Ca/Fort 
Collins/224986/06 in viral transport medium. Purified full-length M gene RNA was used 
as a standard for quantification of influenza virus M gene copy number. Matrix gene 
RNA was transcribed with a large scale RNA production kit (RiboMAX® Large Scale 
RNA production systems kit, Promega, Madison, WI) from the T7 promoter according to 
the manufacturer’s instructions. The RNA generated was treated with RNase-free DNase 
I and tested for purity by both gel electrophoresis and PCR prior to use in real-time RT-
PCR. The purified RNA was suspended in RNase-free water, quantified by 
spectrophotometer and stored at -80°C in 10 µL aliquots. To determine the minimum 
detection level for real-time RT-PCR, the in vitro transcribed RNA was serially diluted in 
RNase-free water to produce dilutions ranging from 107 to 100 copies/mL of M gene 
RNA. To evaluate inter-assay variation, the threshold cycle (Ct) values of 10 RNA 
standard curves, run on different days were determined. The mean, standard error of the 
mean, and coefficient of variation were calculated. The minimum detection level of RNA 
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was determined to be 103 M gene copies/reaction for real-time RT-PCR. Amplification of 
dilutions of the RNA transcripts showed linearity over a range of 6 orders of magnitude. 
The average Ct values corresponding to each dilution of M gene RNA was 15.9 (± 0.13) 
at 108 copies, 19.5 (± 0.14) at 107 copies, 22.9 (± 0.1) at 106 copies, 26.3 (± 0.11) at 105 
copies, 29.9 (± 0.13) at 104 copies, and 33.8 (± 0.3) at 103 copies. Matrix gene RNA at 
102, 101 and 100 copies was either undetectable or detectable at higher Ct (above 36). 
Coefficients of variation were between 1.5 and 4.7% for the Ct values. 
 
Hemagglutination inhibition assay  
Hemagglutination inhibition assays were performed as previously described.21 Briefly, 
sera were pretreated with receptor destroying enzyme (Denko Seiken Co., Tokyo, Japan) 
and incubated overnight at 37°C. Following enzyme inactivation, two-fold serial 
dilutions of sera were mixed with 4 hemagglutination units of Eq/CO and Ca/WY, 
respectively. The assays were developed by adding 0.5% (vol/vol) chicken red blood 
cells and the HI antibody titers were interpreted as the reciprocal of the highest dilution 
causing complete inhibition of agglutination. 
 
Statistical analyses 
Generalized estimating equations were used to analyze the overall mean differences in 
the levels of M gene copy numbers in nasal swab specimens, HI antibody titers, clinical 
scores, and body temperatures between the Ca/WY and Eq/CO infected groups and 
between the infected groups and the mock-inoculated controls. Mean differences were 
adjusted for days and clustered on repeated measures for each outcome in the analysis. 
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Clinical scores were ranked prior to analysis. All other outcome variables were log 
transformed, if necessary, to meet the major assumptions, including linearity and 
normality. HI antibody titers with values of zero were converted to 1 in the challenge 
groups for data transformation and easier statistical analyses. Comparison of M gene 
copy numbers of Ca/WY in ERECs and CRECs at 24 hours post inoculation was 
determined using a one-way ANOVA. M gene copy numbers of Ca/WY in CRECs and 
Eq/CO in ERECs were compared using a student’s T-test. M gene copy numbers were 
log transformed prior to both analyses. Significant differences were determined when 
P<0.05. All statistical analyses were performed using commercially available software 





In vitro growth characteristics 
In MDCK cell cultures, Ca/WY and Eq/CO demonstrated no differences in growth 
kinetics and M gene copy numbers at 24 hours post inoculation (data not shown). 
Similarly, no significant differences were found when comparing the growth and M gene 
copy numbers of Eq/CO in ERECs and Ca/WY in CRECs (P>0.5). Correspondingly, 
visual inspection of the ERECs and CRECs infected with Eq/CO and Ca/WY, 
respectively, and stained with ICC revealed that the viruses were able to infect virtually 
every available cell derived from their respective host species (Figure 3.1). In contrast, 
Ca/WY demonstrated a low infectivity phenotype in ERECs (Figure 3.1), which was 
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paralleled by significantly lower end-point M gene copy numbers (data not shown) 
reached compared to M gene copy numbers achieved in CRECs (P<0.005). 
 
Figure 3.1. ICC staining of virus-infected ERECs and CRECs. From left to right: Ca/WY 
in ERECs and Ca/WY in CRECs; Eq/CO in ERECs and uninfected control ERECs. 
These are representative images. Similar patterns of infection were seen with repeated 
experiments and with cells from multiple animal donors. Magnification is shown at 4X. 
Clinical responses to inoculation 
 
The clinical responses to inoculation in ponies were remarkably different for the two 
viruses. More specifically, after inoculation, all ponies inoculated with Eq/CO developed 
severe mucopurulent nasal discharge of 7-11 days duration, and spontaneous coughing 
for 12-14 days (Figure 3.2). In addition, all five ponies were pyrexic (T > 101.5ºF) for 2-
7 days (Figure 3.3). In contrast, in the Ca/WY inoculated group, only one of five ponies 
developed mild to moderate mucopurulent nasal discharge for 2 days duration. Moreover, 
none of the ponies in the CIV inoculated group developed a cough or pyrexia. 
Statistically, the Eq/CO inoculated ponies showed significantly (P<0.001) more disease, 
as assessed by clinical scores and rectal temperatures, than either the Ca/WY or mock-
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inoculated ponies. No statistical differences (P>0.05) in the clinical scores or rectal 




Figure 3.2. Group mean scores of clinical responses by day for ponies inoculated with 
Eq/CO (◆) along with Eq/CO sentinels (◇) and Ca/WY inoculated ponies (▲). Group 
mean scores of Ca/WY sentinel animals and mock inoculated ponies remained =0 







Figure 3.3. Group means ± standard error (SEMs) of rectal temperatures by day for 
ponies inoculated with either Eq/CO (◆) or Ca/WY (▲), along with Eq/CO sentinels (◇), 




The duration and levels of M gene copies detected in nasal secretions were distinctly 
different between the canine and equine H3N8 virus (Figure 3.4). In the Eq/CO infected 
ponies, the influenza virus M gene was detected in nasal secretions in all five ponies 
starting as early as 2 days after inoculation. Nasal virus shedding was detectable for up to 
8 days with M gene copy numbers of ≥ 104 for at least 5 days in all five ponies. In 
contrast, among animals infected with Ca/WY, in 4 ponies M-gene copies were never 
detected in the nasal swab samples. Only one pony demonstrated real-time RT-PCR 
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positive nasal swab specimens at ≤ 104 M gene copies for two consecutive days (days 5 
and 6) after inoculation. Overall, the mean M gene copy numbers in the nasal swab 
specimens was significantly higher in ponies inoculated with Eq/CO compared to ponies 
inoculated with Ca/WY. In contrast, there were no significant differences in the numbers 
of M gene copies detected in nasal secretions of ponies challenged with Ca/WY and the 





Figure 3.4. Group means ± SEMs of virus shed in the nasal passages by day for ponies 
inoculated with either Eq/CO (◆) or Ca/WY (▲), along with Eq/CO sentinels (◇). The 
minimum detection level of the real-time RT-PCR was 1000 M gene copies per reaction 
corresponding to 100 TCID50 of A/Ca/Fort Collins/224986/06. The Ca/WY sentinels and 
mock-inoculated control animals did not shed detectable levels of virus at any point 




HI antibody responses 
The pattern of systemic antibody responses generally mimicked the differences in the 
severity of clinical signs and extent of nasal virus shedding found between the challenge 
groups. Prior to inoculation, all animals were serologically negative for the equine and 
canine influenza virus (Table 3.1). Seven days post infection, all five ponies inoculated 
with Eq/CO had detectable, low-level virus-specific antibody titers and by day 14 and 
day 21 these titers had increased substantially (≥ 1:1024). In contrast, none of the ponies 
inoculated with Ca/WY developed detectable antibody titers by day 7. Moreover, only 
two of five ponies developed a low-titered antibody response by day 14 (1:64 and 1:16) 
and day 21 (1:64 and 1:4). Statistically, the overall mean HI antibody responses in ponies 
inoculated with the contemporary equine isolate were significantly higher compared to 
the ponies inoculated with the canine isolate. 
 




Pre-challengea Day 7 Day 14 Day 21 
Controlsb 0 0 0 0 
Eq/COc, e 0 32.0 ± 11.0 2560.0 ± 494.6 1356.8 ± 656.7 
Eq/CO sentinelsd, f, e 0 2.7 ± 3.8 768.0 ± 161.9 853.3 ± 358.0 
Ca/WYc 0 0 31.2 ± 35.8 10.4 ± 9.5 
Ca/WY sentinelsd, f 0 0 0 0 
1Serum antibody responses to Eq/CO did not differ significantly from Ca/WY and 
therefore are not represented in this table. 
a Data are means ± SEMs. 
b, c, d Sample sizes for controls, challenge groups and sentinels are n = 4, n = 5, and n = 3, 
respectively; e P < 0.05. 




Virus transmission to sentinels 
To examine the potential for horizontal transmission of virus, three influenza 
seronegative ponies were introduced to the EIV and CIV inoculated groups to serve as 
sentinels. The clinical signs, virus shedding, and antibody responses of the Eq/CO 
sentinels closely mirrored the responses observed in the inoculated animals. More 
specifically, all three ponies exposed to the Eq/CO inoculated animals developed 
mucopurulent nasal discharge, spontaneous coughing, and pyrexia as early as 2 days post 
group introduction (Figures 3.2 and 3.3). In addition, nasal virus shedding was detected 
in all three Eq/CO sentinels on day 3 after introduction and persisted for up to 7 days 
(Figure 3.4). All three sentinels showed influenza-specific seroconversion by day 14 
(Table 3.1). In contrast, none of the Ca/WY sentinels developed any clinical 
abnormalities or shed detectable levels of virus in nasal secretions. Lack of biologically 
relevant virus transmission was further confirmed by the absence of an immune response 




The aims of this study were to evaluate whether a contemporary CIV isolate could infect, 
replicate, cause clinical disease, and spread among ponies and in primary respiratory 
epithelial cells grown in cell culture. While CIV was first identified subsequent to the 
interspecies transfer of an equine-lineage H3N8 virus to dogs,5 the canine viruses have 
since evolved genetically resulting in segregation of the canine genes from the equine H3 
“Florida lineage”.5,6 Based on this genetic diversion, we hypothesized that CIV could 
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represent a disease threat to horses provided the viruses had maintained the ability to 
infect horses. The results of this study indicate that the contemporary canine H3N8 
influenza virus Ca/WY infected and replicated poorly in ponies. Moreover, virus 
inoculation did not result in clinical disease or spread of virus to naïve in-contact ponies. 
By comparison, the contemporary Eq/CO isolate, infected, replicated, and transmitted 
efficiently between ponies. Although the latter finding was not unexpected, based on the 
epidemiology of the outbreak during which Eq/CO was isolated and results of similar 
equine influenza challenge experiments conducted by our group and others,20,26,27 the 
near complete lack of infectivity of the canine isolate in horses is interesting. Ca/WY is 
clearly not an inherently replication-defective virus. This notion is supported by the rapid 
spread of virus among dogs at an animal shelter as well as the efficient growth of the 
virus in MDCK cells and primary canine RECs. In mammals, the primary targets of 
influenza viruses are the airway epithelial cells and these cells are being used with 
increasing frequency to study influenza virus-host interactions. In fact, recent studies 
have demonstrated that primary RECs represent a suitable in vitro system to investigate 
species-specific infection characteristics and host range of influenza A viruses.16-19 In the 
present study, we extended our findings of the in vivo infection characteristics of Ca/WY 
and Eq/CO to an in vitro primary respiratory cell culture system. Although both viruses 
were able to infect and replicate to comparable levels in primary airway epithelial cells 
derived from their respective host species, the viruses displayed distinctly different levels 
of infection and replication efficiencies in primary ERECs. These results closely 
paralleled the infection characteristics observed in ponies, in particular the nasal virus 
shedding data, suggesting that primary ERECs and CRECs could represent a feasible 
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model system to dissect virus and host factors controlling species-specific replication 
characteristics of influenza in horses. Studies are currently being conducted in our 
laboratory to further validate this in vitro system. 
The first step of influenza virus infection is dependent on the interaction of the 
viral HA with cellular sialic acid residues. As such the viral HA is thought to be a major 
contributor of influenza virus host range.15,28 Previous work has shown that CIV isolates 
(including Ca/WY) contain five amino acid differences in their HA protein that are not 
present in the most closely related equine H3 HAs (including Eq/CO) and it has been 
hypothesized that these amino acid substitutions have occurred as a result of mutational 
adaptation of the virus to its new host species.5,6 It is therefore possible that the amino 
acid differences in the HA protein could account for at least part of the observed 
differences in infectivity and replication efficiency of Ca/WY and Eq/CO. For example, 
the isoleucine (I) to threonine (T) substitution at position 328 occurred near the cleavage 
site of the H3 HA protein.7 As the peptide structure connecting the HA1 and HA2 subunit 
has been found to determine tissue tropism of avian influenza virus,29,30 it is possible that 
diminished cleavability of the CIV HA by equine cellular proteases resulted in the 
reduced infectivity of Ca/WY in ponies. Similarly, the N483T substitution results in the 
loss of a glycosylation site in the HA2 subunit,5,6 which has been found to affect the HA’s 
interaction with the host cell receptor and the release of progeny virus from the host 
cell.31 Lastly, the substitution of leucine for tryptophan at position 222 is remarkable 
because it represents a non-conservative change adjacent to the receptor binding 
pocket.5,6 As species-specificity of influenza is partly determined by the binding 
preference of the HA protein to cellular sialic acid species,15,28 modulation of receptor 
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binding specificity as a result of the W222L substitution could provide an attractive 
explanation for the inability of Ca/WY to infect and to replicate in ponies. Currently, 
studies are underway in our laboratory to determine the sialic acid receptor binding 
specificities of canine and equine influenza virus isolates. Finally, while the HA is 
recognized as a key factor controlling the species-specificity of influenza A viruses, it is 
clear that the other seven influenza virus gene segments also contribute to influenza virus 
host range. It is therefore possible that the critical viral factors that impact infection and 
replication of Ca/WY in ponies may include equine to canine amino acid substitutions 
that are present in other gene segments than the HA. 
In summary, our findings indicate that Ca/WY, a contemporary equine-derived 
canine H3N8 influenza virus, has virtually lost the ability to infect, replicate, cause 
clinical disease, and spread among ponies. This was further supported by the significantly 
lower levels of infection and M gene copy numbers of Ca/WY in ERECs compared to the 
Eq/CO isolate. However, while these results appear to support the existence of a barrier 
to CIV infection in horses, it remains to be determined whether other canine isolates 
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CHAPTER 4: CONCLUSION 
 
The primary goal of this Master’s project has been the development and characterization 
of a primary equine respiratory epithelial cell culture model grown at the air-fluid 
interface. Data presented in both papers show that these cultures are morphologically 
similar to equine airway epithelium, retain several immunological characteristics 
important in the host immune defense, and present similar patterns of infection, 
replication, and pathogenesis with influenza virus infection both in vitro and in vivo. The 
experiments performed as part of this project clearly show that we have developed an 
equine airway model that can be used as tool to study host-pathogen interactions. The 
usefulness of this model is considerable. In addition to examining host-pathogen 
interactions including mechanisms of viral immune evasion, pathogen binding and host 
cell entry, this model might also be used to investigate the effects of novel preventatives 
and immunotherapeutics against equine respiratory pathogens.  
Despite vaccination, both EIV and EHV-1 continue to have detrimental effects on 
equine health.1-4 As mentioned previously, antigenic drift represents a significant 
challenge in the continuing development of effective vaccines against EIV. Conversely, 
EHV-1 modulation of host immunity remains an obstacle for EHV-1 vaccine 
development. Novel therapeutics against EIV and EHV-1 might be further investigated as 
we come to learn more about innate and early immunity to equine respiratory viruses at 
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the epithelial cell barrier using the EREC AFI model. For example, one study 
demonstrated that mice pretreated with a TLR3 agonist (poly I:C) had significant 
increases in survival rates after they were challenged with an encephalitic strain of herpes 
simplex virus.5 While this study supports the usefulness of TLR agonists as therapeutics, 
it can often be difficult to apply results of studies in mice to an equine model.  
 When in vivo studies of equine respiratory disease using equine models may 
prove costly and logistically difficult, the EREC AFI model would be a simple, practical, 
and less costly alternative. This is especially true when performing experiments involving 
sequential sampling or repeated measures. As experiments done in vitro are often 
performed in a more controlled environment, this would also limit the possibility of 
confounding effects on experimental studies. For example, EREC AFI cultures might be 
more useful than an in vivo model when studying cell-to-cell interactions or when 
examining the immune responses of specific cell types. In addition, we have 
demonstrated in this project that patterns of infection using H3N8 canine and equine 
influenza A isolates in ponies and in primary RECs cultured at the AFI were similar. 
Therefore, RECs cultured at the AFI could be useful for assessing viral infectivity.  
Secondly, preliminary experiments in our lab have demonstrated that infection of 
the EREC AFI model with EHV-1 down-modulates surface expression of MHC-I and 
MHC-II (data not shown). As EHV-1 has demonstrated immune modulation similar to 
other alpha herpesviruses,6,7 we are currently examining the effects of host 
immunomodulatory genes using deletion mutants of EHV-1 at the epithelial cell barrier 
in the EREC AFI model. In addition, herpesviruses are known to alter the host cytokine 
network.8 We have demonstrated that EREC AFI cultures still express low levels of GM-
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CSF, IL-10, IL-8, TGF-β, TNF-α, and IL-6 after four weeks of in vitro growth 
conditions. Even though IFN-α, IFN-β, IL-1, IL-12, and MCP-1 were not detected in the 
EREC AFI cultures, it would be interesting to see how infection with EHV-1 affects the 
expression in both of these groups of cytokines. Immune modulation by EHV-1 has been 
demonstrated in an in vitro study using peripheral blood mononuclear cells in as early as 
six hours post-infection8. As immune modulation by EHV-1 at the respiratory epithelial 
cell barrier also likely occurs within the first several hours after infection, the EREC AFI 
model could be a suitable alternative to an in vivo study when examining immune 
modulation at the early stages of EHV-1 infection. 
However, while there are several advantages in using this model, some challenges 
do exist. It has been made clear by this project that after four weeks of in vitro growth 
conditions epithelial cells undergo differentiation. However, contaminating fibroblasts 
represent a challenge in cultures of respiratory epithelial cells where in vitro growth 
conditions are suitable for fibroblast cell lines. An essential requirement for in vitro 
epithelial cell culture is the presence of an extracellular matrix. In the case of the EREC 
AFI model, 5% collagen is utilized as this matrix, however, a fibroblast feeder layer is 
probably a more natural form of extracellular matrix secretion.9 While the EREC AFI 
system is a model to study host-pathogen interactions at the epithelial cell barrier, the 
presence of other cells such as contaminating fibroblasts in this model should be taken 
into consideration. While we know that the EREC AFI model is not a pure culture of 
epithelial cells but rather predominately epithelial (65%) in origin, we are currently 
investigating the presence of other cell types in the model.  
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In addition, while the natural airway epithelium and isolated, uncultured, 
epithelial cells expressed TLRs 1-4 and 6-10, after four weeks of in vitro growth 
conditions, TLRs 8 and 10 could no longer be detected in the EREC AFI model using 
conventional PCR techniques. However, antigenic stimulation may restore these 
properties. Previous studies have implicated that TLRs 2, 3, 7, 8, and 9 as well as RNA 
helicases plays a role in the recognition of viruses including influenza and herpesviruses 
among other pathogens.10-15 For example, evidence supports that type I interferon (IFN-α 
and IFN-β) production critical to controlling herpesvirus infection is primarily mediated 
through the toll-like receptor 9 pathway.11,16,17 In addition, TLR2 has been implicated as a 
secondary pathway in the recognition of herpesviruses where TLR2 expressed on the 
surface of antigen-presenting cells recognizes extracellular virions.10,18 Even though 
TLRs 3, 7, and 8 have often been implicated in the recognition of influenza viruses,12,19,20 
some research has indicated that TLR3 serves a role in the recognition of herpesviruses as 
well5. Future studies using this model might investigate how EIV and EHV-1 affect the 
expression of toll-like receptors in airway epithelial cells using real-time PCR for which 
assays are currently being developed. 
Lastly, mRNA expression of β-defensin1, MxA, 2’5’ OAS, and lactoferrin were 
detected in the equine natural airway epithelium and in the isolated epithelial cells, 
however, lactoferrin was no longer detected in the EREC AFI cultures. In addition, 
MHC-I and MHC-II expression was greatly reduced in the EREC AFI cultures compared 
to isolated, uncultured, epithelial cells. As the lack of antigenic stimulation and 
underlying immune cells might account for the reduction in these immunological 
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properties, the loss of these characteristics could possibly be restored after infection with 
EHV-1 or EIV but merits further examination. 
In conclusion the development of the EREC AFI model presents exciting new 
opportunities as a tool to understand host-pathogen interactions at the epithelial cell 
barrier to equine respiratory diseases. For years, our understanding of the innate and early 
immune responses to equine respiratory diseases has been hindered by a lack of a suitable 
in vitro model. The development and characterization of this model will undoubtedly 
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